CDX2 and colorectal carcinoma: We prioritized two poorly differentiated CRC cell lines—HCT116 and SW480—which exhibited the lowest CDX2 transcript levels among 26 sequenced CRC cell lines profiled by microarray (GEO: GSE10843)—as optimal models for hypothesis testing.